Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-06-02 Option Award |
2021-06-02 7:16 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | KISHBAUCH MICHAEL D Director |
100,000 | $0 | 100,000 (Direct) |
View |
2021-06-02 Option Award |
2021-06-02 7:16 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | BATE KENNETH Director |
100,000 | $0 | 100,000 (Direct) |
View |
2021-06-02 Option Award |
2021-06-02 7:15 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | Beck Joanne T. Director |
100,000 | $0 | 100,000 (Direct) |
View |
2021-06-02 Option Award |
2021-06-02 7:15 pm |
N/A 2031-03-31 |
CATABASIS PHARMACEUTICALS INC | CATB | Milne Jill C. CEO and President |
1,400,000 | $0 | 1,400,000 (Direct) |
View |
2021-06-02 Option Award |
2021-06-02 7:14 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | Cole Hugh M Director |
100,000 | $0 | 100,000 (Direct) |
View |
2021-06-02 Option Award |
2021-06-02 7:13 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | LAPOINTE ANTHONY GREGG Director |
100,000 | $0 | 100,000 (Direct) |
View |
2021-06-02 Option Award |
2021-06-02 7:13 pm |
N/A 2031-03-31 |
CATABASIS PHARMACEUTICALS INC | CATB | Harshbarger Benjamin Senior VP, General Counsel |
400,000 | $0 | 400,000 (Direct) |
View |
2021-02-01 Option Award |
2021-02-03 7:15 pm |
N/A N/A |
CATABASIS PHARMACEUTICALS INC | CATB | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Xontogeny LLC Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director 10% Owner |
6,468 | $3,010 | 35,771 (Indirect) |
View |
Ownership |
2021-02-03 7:13 pm |
N/A N/A |
CATABASIS PHARMACEUTICALS INC | CATB | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Xontogeny LLC Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director 10% Owner |
0 | $0 | 40,013,924 (Indirect) |
View |
2021-02-01 Option Award |
2021-02-03 6:45 pm |
N/A N/A |
CATABASIS PHARMACEUTICALS INC | CATB | Callori Fred Director |
1,617 | $3,010 | 30,920 (Indirect) |
View |
2021-01-28 Option Award |
2021-02-01 9:56 pm |
N/A 2031-01-27 |
CATABASIS PHARMACEUTICALS INC | CATB | Violin Jonathan Director |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2021-02-01 9:50 pm |
N/A N/A |
CATABASIS PHARMACEUTICALS INC | CATB | Violin Jonathan Director |
0 | $0 | 739,548 (Indirect) |
View |
2021-01-28 Option Award |
2021-02-01 9:47 pm |
N/A 2031-01-27 |
CATABASIS PHARMACEUTICALS INC | CATB | Callori Fred Director |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2021-02-01 9:45 pm |
N/A N/A |
CATABASIS PHARMACEUTICALS INC | CATB | Callori Fred Director |
0 | $0 | 2,514,461 (Indirect) |
View |
2020-09-17 Option Award |
2020-09-21 08:11 am |
N/A 2030-09-16 |
CATABASIS PHARMACEUTICALS INC | CATB | Clauser Noah Chief Financial Officer |
35,000 | $0 | 35,000 (Direct) |
View |